Valproic Acid Withdrawal May Increase Seizure Risk in Pregnancy
⚠️ Pregnancy-related topic: medication, diet, and testing decisions must be made with your obstetrician and neurology team.
Source: Seizure
Summary
Researchers studied the effects of stopping or switching valproic acid (VPA) in women with epilepsy who were planning to become pregnant or were already pregnant. They looked at various studies to see how these changes affected seizure frequency, side effects, and complications for both mothers and their babies. The review included nine studies, and three of those were used for a deeper analysis, focusing on a total of 277 women who changed their VPA treatment compared to 2,206 women who continued taking it.
The key findings showed that women who stopped or switched from VPA had a higher chance of experiencing tonic-clonic seizures during pregnancy. Specifically, the odds of having these seizures increased by about 73% for those who withdrew from VPA compared to those who stayed on it. Additionally, a significant number of women who stopped taking VPA ended up restarting it later during their pregnancy, indicating that managing epilepsy during this time can be challenging.
This research is important because it highlights the risks associated with changing epilepsy medication during pregnancy, particularly the increased likelihood of seizures. However, the study also has limitations, such as a lack of detailed information on the effects on babies and mothers after pregnancy. More research is needed to understand the long-term outcomes for both mothers and their children when VPA is withdrawn or switched during pregnancy.
Free: Seizure First Aid Quick Guide (PDF)
Plus one plain-language weekly digest of new epilepsy research.
Unsubscribe anytime. No medical advice.
